Menu

Speaking of Science

May 2015's selection of notable quotes

May 1, 2015
The Scientist Staff

© ISTOCK.COM/JGROUP

A fatal disease has been tamed into a chronic condition. The next step is to find a cure. Scientists are innately cautious, and AIDS researchers have learned humility over the years. Science operates around a core of uncertainty, within which lie setbacks, but also hope.

—Harvard Medical School researcher Jerome Groopman, in a New Yorker article about the quest to find a cure for AIDS (December 22 & 29, 2014)

 

For a long time scientists were cautious about referring to a cure. The possibility just seemed so out of reach. But people are talking about it more now than they used to. Several drug companies are shifting away from developing new HIV drugs to pursuing strategies for using existing drugs to eradicate the virus. 

Robert Siliciano, Johns Hopkins University infectious disease researcher who studies HIV latency, on the website of the university’s Institute for Basic Biomedical Sciences

 

The currency of science is fragile, and allowing counterfeiters, fraudsters, bunko artists, scammers, and cheats to continue to operate with abandon in the publishing realm is unacceptable.

—New York University bioethicist Arthur Caplan, in a Mayo Clinic Proceedings commentary about problems in science publishing (April 3)

 

I think we’re going to have strong indications of life beyond Earth within a decade, and I think we’re going to have definitive evidence within 20 to 30 years.

Ellen Stofan, NASA chief scientist, speaking during a recent NASA panel discussion about the search for water in the universe (April 7)

 

As HIV investigators continue the campaign to control and conceivably eradicate HIV worldwide, certain directions reflecting myths or misconceptions about this infectious disease have been embraced, while other concepts with merit have been left relatively unexplored. These issues in HIV pathogenesis threaten to prevent a true long-term solution to HIV infection and, perhaps, infections by other human pathogens. 

—Prominent HIV researcher Jay Levy of the University of California, San Francisco, in a recently published opinion article about HIV research (Trends in Molecular Medicine, April 14)

 

Most work going on in brain imaging is of no scientific value.

Margaret Boden, cognitive scientist at the University of Sussex, U.K., speaking with New Scientist about understanding human consciousness (March 31)

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.

Thermo Fisher Scientific: Freezers for Biological Samples

Thermo Fisher Scientific: Freezers for Biological Samples

Fluctuations in temperature can reduce the efficacy, decompose, or shorten the shelf life of biologics. Therefore, it is important to store biologics at the right temperature using standardized protocols.